- Fatigue and reduced exercise capacity associated with MASLD- Comorbidities limiting exercise options (joint pain, cardiovascular disease)- Sarcopenia affecting exercise capability- Psychological symptoms (depression, anxiety) affecting motivation- Insulin resistance creating physiological barriers to weight management- Poor sleep quality compromising metabolic health and exercise recovery- Medication side effects interfering with physical activity. This evidence concerns the gene INS and major depressive disorder.